Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective

Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective

Past failures in clinical trials have dampened the enthusiasm for studying the HGF receptor MET and postponed the development of MET-targeted drugs for cancer therapy. However, new evidence suggests that, at least in liver cancer, MET is still a promising therapeutic target, and may also be a potent...

Full description

Bibliographic Details
Main Authors: Xing Huang, Gang Zhang, Xueli Bai, Tingbo Liang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
met
targeted therapy
drug resistance
autophagy
mtor
tumor immunity
cancer vaccine
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1818438

Similar Items

Similar Items